Clinical Trial

Pan-Facial Layering of Hyaluronic Acid Filler

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Recent advancements in anatomical studies have enabled a more sophisticated approach to treating patients with facial aesthetic concerns with hyaluronic acid (HA) fillers. For instance, volumizing a specific area of concern may be warranted, but it is essential to understand how the underlying patient anatomy is continuing to laxity and hollowness. Varying manufacturing technology have offered a range of HA fillers with different physical and chemical properties adapted to different indications, each one tailored to provide a slightly different outcome based on the needs of the patient. Given these advances in the medical aesthetic field, investigators and clinicians are seeking to develop a new methodology for providing patients with a more tailored and personalized treatment approach. This methodology includes using a pan-facial, multilayering treatment technique that can be employed by injectors once experience is gained with standard techniques. The goal of this study is to assess the efficacy and safety of layering HA from the Restylane line of soft tissue products to create a more harmonious and complete aesthetics results.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-07-03; most recent amendment 2026-06-17.
Status change: Recruiting → Active, Not Recruiting 2026-06-17
Trial Details
NCT Number NCT07063511
Lead Sponsor Erevna Innovations Inc.
Conditions Aesthetic
Enrollment 30 participants
Start Date 2025-07-02
Primary Completion 2026-05-22 (estimated)
Study Completion 2026-06-22 (estimated)
Updated on ClinicalTrials.gov 2026-06-22